Inhalation Sciences signs new IRS contract with returning customer

Report this content

(Stockholm 23 June 2022) Inhalation Research Services (IRS), ISAB’s contract research organization, has signed a contract worth 581,000 SEK with a returning customer following a previous successful research project in February 2022. 

The customer will once again be using ISAB’s in vivo intratracheal exposure module which delivers voluminous data with exceptionally high precision. Unlike conventional ‘tower testing’ technologies it delivers aerosol directly to the lungs of an individual test rodent, bypassing its nose, whilst carefully monitoring aerosol concentration and individual breathing patterns.

The customer will also be using ISAB’s ex vivo Isolated Perfused Lung (IPL) solution, specially tailored for aerosols generated by the PreciseInhale® system, which delivers low standard deviation dosing rates and high-resolution data of unprecedented quality and detail.

ISAB CEO Manoush Masarrat: “We’re delighted that this returning customer has chosen once again to use IRS for its highly innovative research. This is a testament to the success of our previous project and the excellent results our high-precision technology delivers. We look forward to continuing our cooperation.”

For more information about Inhalation Sciences, please contact:

Manoush Masarrat, CEO


Mobile: +46 (0)73 628 9153

About Inhalations Sciences Sweden AB (publ)

Inhalation Sciences Sweden AB (publ) develops and commercializes world-leading instruments and services for research into inhalation. The company’s patented lab instruments PreciseInhale® and DissolvIt® enable researchers in the pharma industry to make drug pipeline decisions at an early stage, saving time and resources for R&D departments, and enables researchers in academic institutions to define how aerosols and small particles impact our lungs, and so our health, when being inhaled.

The information above was provided by Inhalation Sciences Sweden AB according to EU Market Abuse Regulations. The information was provided, through the above contact person, for publication on June 23, 2022.



Documents & Links